Actoplus Met (Takeda Pharmaceuticals America, Inc.)
Welcome to the PulseAid listing for the Actoplus Met drug offered from Takeda Pharmaceuticals America, Inc.. This Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Takeda Pharmaceuticals America, Inc. |
NON-PROPRIETARY NAME: | pioglitazone and metformin hydrochloride |
SUBSTANCE NAME: | PIOGLITAZONE HYDROCHLORIDE; METFORMIN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2005-08-29 |
END MARKETING DATE: | 0000-00-00 |
Actoplus Met HUMAN PRESCRIPTION DRUG Details:
Item Description | Actoplus Met from Takeda Pharmaceuticals America, Inc. |
LABELER NAME: | Takeda Pharmaceuticals America, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 15; 500(mg/1; mg/1) |
START MARKETING DATE: | 2005-08-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 64764-155_d3ddc329-a501-4086-a821-901d9461d4cb |
PRODUCT NDC: | 64764-155 |
APPLICATION NUMBER: | NDA021842 |
Other PIOGLITAZONE HYDROCHLORIDE; METFORMIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: